Meridian Bioscience, Inc.
Quick facts
Marketed products
- Esomeprazole (Nexium) · Gastroenterology
Esomeprazole irreversibly inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion. - Lansoprazole (Lanton) · Gastroenterology
Lansoprazole inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion. - Omeprezole (Losec) · Gastroenterology
Omeprazole irreversibly inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion. - Pantoprazole(Controloc) · Gastroenterology
Pantoprazole irreversibly inhibits the proton pump in gastric parietal cells, reducing gastric acid secretion.
Phase 3 pipeline
- BreathID® Hp Lab System · Gastroenterology / Infectious Disease
BreathID® Hp is a non-invasive diagnostic system that detects Helicobacter pylori infection by measuring labeled carbon dioxide in exhaled breath.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: